News & Updates
Filter by Specialty:

Functional surgery delivers amputation-free benefit in nail unit melanoma
Patients who have nail unit melanoma (NUM) with a Breslow thickness (BT) of <0.8 mm may benefit from functional surgery, which offers an amputation-sparing advantage, suggests a recent study.
Functional surgery delivers amputation-free benefit in nail unit melanoma
29 May 2023
HCT treatment tied to lower cancer risk, except skin cancer
Treatment with hydrochlorothiazide (HCT) contributes to a lower all-cancer risk and a slightly higher skin cancer risk compared with alternative diuretics, reports a study involving a German population.
HCT treatment tied to lower cancer risk, except skin cancer
26 May 2023
Vitamin D supplementation exerts no effect on psoriasis severity in vitamin D-deficient individuals
Supplementation with vitamin D falls short of reducing psoriasis severity for individuals with 25-hydroxyvitamin D (25[OH]D) levels of <24 ng/mL, as reported in a study.
Vitamin D supplementation exerts no effect on psoriasis severity in vitamin D-deficient individuals
22 May 2023
Second primary melanoma tied to better survival than single primary lesion
Patients who present with second primary melanomas have better survival and thinner lesions than those presenting with single primary melanomas, reveals a study.
Second primary melanoma tied to better survival than single primary lesion
06 May 2023
Immune-related AEs predict survival in cancer patients on ICI
Developing cutaneous immune-related adverse events (cirAEs) among advanced cancer patients on immune checkpoint inhibitor (ICI) appears to be a sign of longer overall survival, particularly in those with melanoma, suggests a recent study.
Immune-related AEs predict survival in cancer patients on ICI
05 May 2023
Tralokinumab a promising treatment option in young people with moderate-to-severe AD
Targeting interleukin (IL)-13 with tralokinumab monotherapy helps reduce disease activity in adolescents with moderate-to-severe atopic dermatitis (AD) with a low frequency of conjunctivitis throughout the treatment period, according to data from the phase III ECZTRA 6 trial.
Tralokinumab a promising treatment option in young people with moderate-to-severe AD
29 Apr 2023
HK doctors’ mental HRQoL significantly worse than the general population
Doctors in Hong Kong have significantly poorer mental health-related quality of life (HRQoL) than the general population, with high rates of depression and burnout, a survey has shown.
HK doctors’ mental HRQoL significantly worse than the general population
25 Apr 2023
SG: Acne in youths managed suboptimally in primary care
The prescribing patterns for acne among local primary care physicians appear to deviate from clinical practice guidelines used to achieve optimal outcomes for young people, as shown in a Singapore study.